APA (7th ed.) Citation

Matsumura‐Kimoto, Y., Tsukamoto, T., Shimura, Y., Chinen, Y., Tanba, K., Kuwahara‐Ota, S., . . . Kuroda, J. (2020). Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma. Cancer Medicine, 9(14), 5185. https://doi.org/10.1002/cam4.3136

Chicago Style (17th ed.) Citation

Matsumura‐Kimoto, Yayoi, et al. "Serine‐227 in the N‐terminal Kinase Domain of RSK2 Is a Potential Therapeutic Target for Mantle Cell Lymphoma." Cancer Medicine 9, no. 14 (2020): 5185. https://doi.org/10.1002/cam4.3136.

MLA (9th ed.) Citation

Matsumura‐Kimoto, Yayoi, et al. "Serine‐227 in the N‐terminal Kinase Domain of RSK2 Is a Potential Therapeutic Target for Mantle Cell Lymphoma." Cancer Medicine, vol. 9, no. 14, 2020, p. 5185, https://doi.org/10.1002/cam4.3136.